In Vitro Antimicrobial Susceptibility Profiles of Gram-Positive Anaerobic Cocci Responsible for Human Invasive Infections.
Anaerococcus
Finegoldia magna
GPAC
Parvimonas micra
Peptoniphilus
Peptostreptococcus anaerobius
antimicrobial resistance
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
04 Aug 2021
04 Aug 2021
Historique:
received:
03
07
2021
revised:
29
07
2021
accepted:
30
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
The aim of this multicentre study was to determine the in vitro susceptibility to anti-anaerobic antibiotics of Gram-positive anaerobic cocci (GPAC) isolates responsible for invasive infections in humans. A total of 133 GPAC isolates were collected in nine French hospitals from 2016 to 2020. All strains were identified to the species level (MALDI-TOF mass spectrometry, 16S rRNA sequencing). Minimum inhibitory concentrations (MICs) of amoxicillin, piperacillin, cefotaxime, imipenem, clindamycin, vancomycin, linezolid, moxifloxacin, rifampicin, and metronidazole were determined by the reference agar dilution method. Main
Identifiants
pubmed: 34442745
pii: microorganisms9081665
doi: 10.3390/microorganisms9081665
pmc: PMC8398781
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Anaerobe. 2020 Apr;62:102150
pubmed: 31987991
Anaerobe. 2020 Aug;64:102245
pubmed: 32707228
Anaerobe. 2020 Aug;64:102220
pubmed: 32531434
Antimicrob Agents Chemother. 2006 Aug;50(8):2728-31
pubmed: 16870765
Clin Microbiol Infect. 2007 Oct;13(10):985-92
pubmed: 17714522
J Antimicrob Chemother. 2007 Jan;59(1):132-9
pubmed: 17095529
Antimicrob Agents Chemother. 2007 Jun;51(6):2205-7
pubmed: 17403999
Antimicrob Agents Chemother. 2011 Mar;55(3):1199-203
pubmed: 21189338
Antimicrob Agents Chemother. 1992 Mar;36(3):662-4
pubmed: 1622181
Anaerobe. 2016 Dec;42:145-151
pubmed: 27756620
Antimicrob Agents Chemother. 2010 Sep;54(9):3993-7
pubmed: 20585132
Antibiotics (Basel). 2020 Jun 19;9(6):
pubmed: 32575377
Anaerobe. 2018 Dec;54:61-64
pubmed: 30114441
Anaerobe. 2005 Feb-Apr;11(1-2):93-5
pubmed: 16701537
Clin Infect Dis. 2014 Sep 1;59(5):698-705
pubmed: 24867792
J Antimicrob Chemother. 2004 Jul;54(1):240-2
pubmed: 15150170
Antimicrob Agents Chemother. 2001 Feb;45(2):630-2
pubmed: 11158770
Antimicrob Agents Chemother. 2020 Aug 20;64(9):
pubmed: 32631819
Int J Antimicrob Agents. 2008 Apr;31(4):316-20
pubmed: 18180149
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29483114
Syst Appl Microbiol. 2011 Feb;34(1):58-62
pubmed: 21292417
Anaerobe. 2019 Oct;59:49-53
pubmed: 31103531
Int J Antimicrob Agents. 1998 Aug;10(3):229-36
pubmed: 9832284
Anaerobe. 2018 Jun;51:78-88
pubmed: 29679648
Antibiotics (Basel). 2017 Nov 07;6(4):
pubmed: 29112122
Anaerobe. 2019 Feb;55:40-53
pubmed: 30316817
J Antimicrob Chemother. 2014 Aug;69(8):2056-60
pubmed: 24710027
Anaerobe. 2014 Aug;28:120-5
pubmed: 24923267
Antimicrob Agents Chemother. 2018 Mar 27;62(4):
pubmed: 29439961
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28993327
Anaerobe. 2020 Jun;63:102200
pubmed: 32247001
Clin Microbiol Infect. 2019 Jun;25(6):760.e1-760.e6
pubmed: 30217761
Ann Lab Med. 2019 Mar;39(2):190-199
pubmed: 30430782
J Antimicrob Chemother. 2006 May;57(5):992-8
pubmed: 16507560
Eur J Microbiol Immunol (Bp). 2020 Jun 05;10(2):64-75
pubmed: 32590337
Antimicrob Agents Chemother. 2001 Apr;45(4):1238-43
pubmed: 11257040
J Antimicrob Chemother. 2003 Aug;52(2):224-8
pubmed: 12837734
Clin Microbiol Infect. 2016 Sep;22(9):793-798
pubmed: 27404365
J Antimicrob Chemother. 2004 Jun;53(6):1039-44
pubmed: 15128729
J Clin Microbiol. 2006 Dec;44(12):4471-8
pubmed: 17050816
Clin Microbiol Rev. 1998 Jan;11(1):81-120
pubmed: 9457430
FEMS Microbiol Rev. 2013 Jul;37(4):520-53
pubmed: 23030831
Drugs. 2010 May 7;70(7):841-58
pubmed: 20426496